President Donald Trump speaks speaks on the latest developments of the coronavirus outbreak, while flanked by White House coronavirus response coordinator Debbie Birx (L), and U.S. Surgeon General Jerome Adams (R), in the James Brady Press Briefing Room at the White House March 19, 2020. (Photo by Chip Somodevilla/Getty Images)
President Donald Trump in a press conference on Thursday said the Food and Drug Administration is fast-tracking efforts to approve an antiviral therapy, best known for treating malaria, for use in coronavirus cases.
The drug, hydroxychloroquine, was developed more than a half-century ago and is approved for treating malaria, arthritis, and other ailments. Reports out of China and Italy suggest the drug may help, but there is no hard data yet.
"We're going to be able to make that drug available almost immediately," Trump said.
The FDA is working to conduct a "large, pragmatic clinical trial" quickly to confirm the drug's benefit to coronavirus patients, said Commissioner Dr. Stephen Hahn.
He also tempered the president's optimism about the still-untested solution.
"What's also important is not to provide false hope," he said. "We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good."
New antiviral therapies face a shorter and less arduous approval process than vaccines, several of which are under development with 12 to 18-month timelines.
"The therapies are something we could move on much faster potentially," Trump said.
He claimed the administration "slashed red tape" to develop new vaccines and therapies.
The president also held out on confirming whether he would invoke the Defense Production Act, which he signed on Wednesday, to mandate the production of needed medical supplies such as N95 respirators and surgical masks.
"If we find that we need something, then we will do that," he said.
Trump repeated that he was open to the federal government buying equity stakes in the airline, cruise, hospitality, and other industries hurt by the outbreak.
The press conference opened with more controversial language placing the blame squarely on China for the outbreak, despite concerns voiced about potentially exacerbating a backlash against Asian Americans.
"We continue our relentless effort to defeat the Chinese virus," Trump said.
Alex Gangitano, White House Correspondent for The Hill, joined Cheddar to discuss the chaos surrounding democrats in congress as they try to advance President Biden's agenda.
Kathy Mulvey, the Accountability Campaign Director for the Union of Concerned Scientists, joined Cheddar News to break down Thursday's congressional hearing on climate change with big oil executives and lobbyists.
Carlo and Baker cover Facebook's big rebrand, the latest on Biden's economic agenda and more. Plus, ranking the best Halloween candy and the worst couple's costumes.
As President Joe Biden heads to Europe for the G20 and the United Nations COP26 climate meeting, he has announced a new $1.75 trillion spending framework. Senate Democrats are reportedly close to agreeing on passing the legislation, but it hangs in the balance as President Biden and other world leaders will meet at COP26 and Biden looks to proclaim the U.S. a leader on climate issues. Vox Senior Reporter Rebecca Leber joins Cheddar News' Closing Bell to discuss the $555 billion worth of clean energy initiatives Biden included in the framework, and how Democrats' continuing negotiations undermine U.S. climate leadership.
Christopher Romaka, advocacy lead at Good Counsel Services, explains how the non-profit is still working to get Afghan refugees out of the country, which fell to the Taliban back in August.
Dems race for a deal on President Biden's economic agenda ahead of his big foreign trip. What to make of the latest threat assessment in Afghanistan. Plus, the meme cryptocurrency of the moment that's now worth more than many Fortune 500 companies.
The U.S. has now joined a handful of countries that allow a gender designation other than 'male' or 'female' on passports. Chris Johnson, White House Reporter for the Washington Blade, joined Cheddar to discuss.
